Sales & Marketing
Changing Faces: Agency, consultancy, and investor hires, Jun...
Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.
News
Sandoz adds 10 biosimilars through $322m Henlius deal
Sandoz is set to add up to 10 new biosimilar assets to its portfolio under a new collaboration deal with China’s Shanghai Henlius Biotech.
News
Pfizer, Valneva Lyme vaccine starts review in Europe
After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.
News
BMS bags first approval for myeloma CELMoD Zenbexus
Bristol Myers Squibb's CELMoD pipeline has delivered its first approval, for iberdomide, as part of a combination regimen for multiple myeloma.
News
FDA cites 'significant concerns' with ADC lymphoma trial
ADC Therapeutics' chances of upgrading its accelerated approval for DLBCL therapy Zynlonta to a full approval have taken a knock.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
